Stiolto Respimat

Boehringer Ingelheim Pharmaceuticals Inc.🇺🇸 United States

FDA Page

Effective Date: May 23, 2023
Approval ID: 01e15aee-40e0-23f3-537f-c96dd63e2cb1
Products: 1 registered
Version: 11

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use STIOLTO RESPIMAT safely and effectively. See full prescribing information for STIOLTO RESPIMAT. STIOLTO RESPIMAT (tiotropium bromide and olodaterol inhalation spray), for oral inhalation use Initial U.S. Approval: 2015

Quick Stats

Total Products1

Labelers3

Label Sections26

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.